Our findings suggest that CARD9 may server as a potential therapeutic target in suppressing chronic inflammation associated with obesity and related metabolic disorders characterized by defective lipid metabolism. The gene discussed is CARD9; the disease is obesity due to melanocortin 4 receptor deficiency.